In a study conducted in veterans who had a history of basal cell carcinoma (BCC) or squamous cell carcinoma (SCC), patients who used a cream containing 5% fluorouracil (5-FU) (multiple brands) on ...
FRIDAY, Jan. 5, 2018 -- For people who've battled certain common forms of skin cancer, use of a generic cream called 5-FU may greatly reduce the odds that the disease will come back, new research ...
Results of a new randomized, double-blinded, controlled clinical trial in veterans showed a 75 percent reduction in the risk of needing surgery to treat a squamous cell carcinoma for a year after ...
Using the generic skin cream fluorouacil 5 percent (5-FU) for two to four weeks may reduce the risk for squamous cell carcinoma (SCC) for up to a year, according to a study published in JAMA ...
A topical therapy applied to sun-damaged skin twice a day for 4 days induced a long-lasting T-cell immunity that was associated with a 3-year decrease in the risk of squamous cell carcinoma (SCC), ...
PURPOSE: To compare protracted venous infusion (PVI) fluorouracil (5-FU) with PVI 5-FU plus mitomycin (MMC) in patients with advanced pancreatic cancer in a multicenter, prospectively randomized study ...
Tens of millions of Americans develop sun-linked skin lesions called actinic keratoses, which are tied to later cancer risk. Many will get a combo of treatments to help clear the blemishes. Now, ...
The relationship between TACC3 expression and chemotherapy resistance in locally advanced rectal cancer patients. This is an ASCO Meeting Abstract from the 2018 ASCO Annual Meeting I. This abstract ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. A single injection of 5-fluorouracil mixed with ...
Saladax Biomedical's MY5-FU blood test will help personalize and optimize 5-fluorouracil dosing in cancer patients. Saladax Biomedical, Inc. announced today that Saladax Biomedical Laboratories is ...
PROVIDENCE, R.I. [Brown University] -- New results from a clinical trial involving more than 900 military veterans at high risk for keratinocyte carcinoma skin cancer provides evidence that using the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback